|
|
||||||||
The Annals of Thoracic Surgery, Vol 22, 157-162, Copyright © 1976 by The Society of Thoracic Surgeons
EC James, GF Schuchmann, RV Hall, JR Patterson, JT Gillespie and AC Gomez
An analysis of our experience with 48 patients having bronchiolar or
alveolar cell carcinoma is reported. The remarkable biological variability
of this peripheral tumor has important surgical implications. Basically,
two dominant clinical presentations occur. In the less common diffuse or
multinodular form, prolonged survival is infrequent regardless of the
therapeutic approach. Often these patients die from respiratory compromise
due to the tumor itself. In the more common localized or solitary form the
prognosis for cure is good, approximating 47% or higher. Based on the
material presented, lobectomy is the preferred method of surgical
treatment. In patients manifesting multinodular disease, surgical resection
rarely seems warranted. The concept of preserving pulmonary tissue is
stressed.
ARTICLES
Preferred surgical treatment for alveolar cell carcinoma
This article has been cited by other articles:
![]() |
O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-P. Hsu, C.-Y. Chen, and N.-Y. Hsu BRONCHIOLOALVEOLAR CARCINOMA J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 374 - 381. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |